1. United States of America Stocks

  2. •

    Healthcare

  3. •

    Drug Manufacturers - Specialty & Generic
Targeted Medical Pharma, Inc.

Targeted Medical Pharma, Inc.

TRGM
Targeted Medical Pharma, Inc.US flagOther OTC
0.00
USD
- -
- -
302.00Market Cap
2008 Y
2009 Y
2010 Y
2011 Y
2012 Y
2013 Y
2014 Y
2015 Y
TTM
Revenue per Share
0.55
0.56
0.35
0.4
0.33
0.4
0.27
0.19
0.19
Basic EPS, GAAP
0.15
0.18
0.15
-0.19
-0.43
-0.39
-0.15
-0.11
-0.11
Free Cash Flow per Basic Share
- -
- -
-0.01
-0.14
-0.12
-0.09
0.03
-0.05
-0.05
Dividend per Share
- -
- -
- -
- -
- -
- -
- -
- -
- -
Book Value per Share
0.18
0.36
-0.01
-0.19
-0.62
-0.97
-1.02
-1.1
-1.11
Tangible Book Value per Share
0.31
0.41
0.03
-0.08
-0.2
-0.38
-0.45
-0.53
-0.53
Basic Weighted Avg Shares
22
22
22
22
22
24
26
27
27
Sales/Revenue/Turnover
12
12
8
9
7
10
7
5
5
Operating Margin (%)
38.26
47.21
-20.67
-65.62
-84.15
-40.2
-36.71
-38.58
-38.58
Depreciation Expense
- -
- -
- -
- -
- -
- -
- -
- -
- -
Net Income, GAAP
3
4
3
-4
-10
-9
-4
-3
-3
Effective Tax Rate (%)
0.43
30.92
- -
- -
- -
- -
- -
- -
- -
Profit Margin (%)
27.9
32.65
42.63
-47.41
-131.38
-97.72
-54.76
-57.86
-57.86
Working Capital
9
12
- -
-5
-10
-9
-12
-14
-14
LT Debt
- -
- -
- -
- -
- -
1
- -
1
1
Total Equity
7
11
3
1
-2
-7
-10
-13
-13
Return on Invested Capital (%)
- -
44.27
- -
- -
- -
- -
- -
- -
- -
Return on Capital (%)
- -
67.55
- -
- -
- -
- -
- -
- -
- -
Return on Common Equity (%)
- -
67.55
- -
- -
- -
- -
- -
- -
- -

Capital Structure

FRC

•

in mil. unless spec.
Jun'15
Sep'15
Dec'15
ST Debt
4
4
5
LT Borrowings
1
1
1
LT Finance Leases
- -
- -
- -
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
27
28
27
Market Capitalization
3
- -
- -

Working Capital

FRC

•

in mil. unless spec.
Jun'15
Sep'15
Dec'15
Total Current Assets
1
1
1
Cash, Cash Equivalents & STI
- -
- -
- -
Accounts Receivable, Net
- -
- -
- -
Inventories
- -
- -
- -
Total Current Liabilities
13
14
15
Payables & Accruals
9
6
6
ST Debt
4
4
5
Deferred Revenue
- -
- -
- -

Growth Rates

FRC

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
- -
-37.29%
29.56%
Free Cash Flow
- -
380.01%
-263.86%
Net Income, GAAP
- -
-36.36%
-21.85%
Sales/Revenue/Turnover
- -
-4.45%
-26.03%
Total Cash Common Dividend
- -
- -
- -

Quarterly Revenue

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2013
3
2
2
3
10
2014
2
2
2
1
7
2015
1
1
2
1
5

Quarterly Earnings Per Share

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2013
-0.01
-0.34
-0.07
- -
-0.39
2014
-0.04
-0.02
-0.04
- -
-0.15
2015
-0.06
-0.02
-0.01
- -
-0.11

Quarterly Dividends Per Share

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2013
- -
- -
- -
- -
- -
2014
- -
- -
- -
- -
- -
2015
- -
- -
- -
- -
- -

Company Description

APIChat
CEO
Kim Giffoni
Full Time Employees
30
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Address
2980 Beverly Glen Circle Los Angeles CA United States of America 90077
IPO Date
Nov 2, 2012
Website
targetedmedicalpharma.com
Similar Companies
Shanghai Jiaoda Onlly Co.,Ltd (600530.SS)
Green Growth Brands Inc. (GGBXF)
CLS Holdings USA, Inc. (CLSH)
Xebra Brands Ltd. (XBRA.CN)
Eisai Co., Ltd. (4523.T)
Unrivaled Brands, Inc. (UNRV)
Business
Targeted Medical Pharma, Inc. (TRGM) is a specialty pharmaceutical company doing business as Physician Therapeutics that develops and commercializes amino acid-based medications, including patented prescription medical food products, dietary supplements, and generic drugs, primarily targeting chronic conditions such as metabolic syndrome and obesity; sleep disorders associated with anxiety or depression, fibromyalgia, and PTSD; hypertension; viral infections; cognitive disorders and fatigue; pain disorders and inflammatory conditions; osteoarthritis and joint disorders; and peripheral neuropathy. The company also offers proprietary billing processes and supporting software (PDRx) that facilitate physician dispensing, inventory control, and regulatory reporting. These products are distributed in the United States through networks of distributors, directly to physicians, pharmacies, and patients. Founded in 1996 and headquartered in Los Angeles, California, the company operates within the biotechnology and medical nutrition sectors, serving healthcare providers and patients focused on nutritional therapies for disease states. Targeted Medical Pharma manufactures approximately 10 proprietary prescription-only medical foods and 48 convenience-packed kits pairing medical foods with branded or generic pharmaceuticals. In 2006, the company changed its name from Targeted Medical Foods, Inc. to Targeted Medical Pharma, Inc., marking a strategic shift to broaden its pharmaceutical focus. No significant recent partnerships, acquisitions, funding rounds, new product launches, or major operational expansions have been reported in the last 1-2 years, with the most recent financial data reflecting trailing twelve-month revenue of $5.26 million and ongoing operations as a microcap entity on OTC Markets.

Company News

APIChat

  • defenseworld.net

    Targeted Medical Pharma (OTCMKTS:TRGM) Stock Price Crosses Above 50 Day Moving Average – Should You Sell?